K961325

Substantially Equivalent

ACCUSIGN DOA 3/DOA 3 (BZO/BAR/PCP), BZO/BAR/PCP, BIOSIGN DOA 3/BZO/BAR/PCP, BIOSIGN BZO/BAR/PCP

Applicant: Princeton BioMeditech Corp.
Product code: JXM
Advisory panel: Clinical Toxicology
Date received: 1996-04-08
Decision date: 1996-06-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.